Home > Cashflow Statement > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Investing Activities ₹1,705 Cr₹-1,757 Cr₹1,208 Cr₹-1,003 Cr₹-1,524 Cr

What is the latest Cash Flow from Investing Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Investing Activities ratio of GLAND PHARMA is ₹1,705 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Investing Activities
Mar2025₹1,705 Cr
Mar2024₹-1,757 Cr
Mar2023₹1,208 Cr
Mar2022₹-1,003 Cr
Mar2021₹-1,524 Cr

How is Cash Flow from Investing Activities of GLAND PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2025 ₹1,705 Cr
Positive
Mar2024 ₹-1,757 Cr
Negative
Mar2023 ₹1,208 Cr
Positive
Mar2022 ₹-1,003 Cr
Negative
Mar2021 ₹-1,524 Cr -

Compare Cash Flow from Investing Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,770.6 Cr 2.5% 3.8% 21.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,185.0 Cr 3.5% 12.3% 5.6% Stock Analytics
DIVIS LABORATORIES ₹171,766.0 Cr 2.8% 7.2% 7.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,923.0 Cr 3.8% 12.1% 42.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,081.0 Cr 3% 9.1% 11.6% Stock Analytics
CIPLA ₹109,680.0 Cr 1.2% 2.8% -9.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.5%

3.8%

21.4%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses